Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Short Interest Update

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) was the target of a large growth in short interest during the month of April. As of April 30th, there was short interest totaling 17,577 shares, a growth of 100.9% from the April 15th total of 8,749 shares. Based on an average trading volume of 220,825 shares, the days-to-cover ratio is currently 0.1 days. Approximately 0.0% of the company’s shares are short sold.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 0.3%

SGIOY stock traded up $0.03 during midday trading on Friday, hitting $9.70. 129,320 shares of the company’s stock were exchanged, compared to its average volume of 177,301. The business has a 50-day simple moving average of $10.42 and a two-hundred day simple moving average of $9.79. The company has a current ratio of 5.84, a quick ratio of 5.21 and a debt-to-equity ratio of 0.01. The stock has a market capitalization of $16.51 billion, a PE ratio of 12.13, a P/E/G ratio of 0.71 and a beta of 0.10. Shionogi & Co., Ltd. Unsponsored ADR has a 1-year low of $7.56 and a 1-year high of $12.00.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last posted its earnings results on Tuesday, May 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.15 by $0.03. The company had revenue of $881.71 million during the quarter, compared to analysts’ expectations of $895.52 million. Shionogi & Co., Ltd. Unsponsored ADR had a return on equity of 14.09% and a net margin of 41.08%. On average, sell-side analysts predict that Shionogi & Co., Ltd. Unsponsored ADR will post 0.78 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on SGIOY shares. The Goldman Sachs Group raised Shionogi & Co., Ltd. Unsponsored ADR to a “hold” rating in a research note on Wednesday, April 8th. Zacks Research downgraded Shionogi & Co., Ltd. Unsponsored ADR from a “hold” rating to a “strong sell” rating in a research note on Thursday, April 16th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Reduce”.

Shionogi & Co., Ltd. Unsponsored ADR Company Profile

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.